Delivery Order SPE2DB22D3301-SPE2DB24FZ3GH

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Carvedilol ER 80 mg capsules. The $3,118.45 contract has a completion date of November 28, 2023 and was awarded on November 27, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for supplying a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 80 mg capsules. The contract, valued at $9,589.49, has an ultimate completion date of August 8, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 40 mg capsules. The contract has a ceiling value of $18,940.52 and an ultimate completion date of September 11, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 80 mg capsules. The contract has a ceiling value of $14,405.12 and a period of performance through July 2024. AmerisourceBergen, the prime contractor, will provide these prescription medications to support federal healthcare programs and agencies. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Carvedilol ER 80 mg capsules, a cardiovascular medication, with a ceiling value of $44,507.05 and a completion date of July 19, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Carvedilol ER 80 mg capsules, a cardiovascular medication, with a total ceiling value of $11,776.99 and a completion date of January 8, 2024. The contract is a firm-fixed price type and is not associated with any set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a $18,328.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Carvedilol ER 40 mg capsules, which are critical pharmaceutical products used to support military treatment facilities and federal healthcare programs. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA...
This is a delivery order under a larger indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,566,026,273 units of the prescription drug Carvedilol ER 40 mg capsule. The total ceiling value of this delivery order is $5,863.99, with a firm fixed price. The period of performance runs through October 7, 2024. This contract does not utilize any set-aside...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $44,761.17 firm-fixed-price contract is for the delivery of Carvedilol ER 80 mg capsules, a medication used to treat cardiovascular conditions. The contract has an ultimate completion date of November 30, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,503.49, is for the supply of Carvedilol ER 80 mg capsules. The contract has a completion date of February 3, 2025 and is a Firm Fixed Price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3GH
    Delivery Order

This is a delivery order under a broader Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Carvedilol ER 80 mg capsules, a pharmaceutical product used to treat certain heart conditions. The delivery order has a ceiling value of $1,672.20 and a completion date of August 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds this IDC valued up to $999,999,999 through December 2025 to provide a wide range of medical commodities in support of military treatment programs and facilities worldwide. The company also holds another IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs. This contract award does not have a set-aside designation.

Generated 11/18/24, 9:40 AM